[1]
Y. Ahmad, “BIOMARKER-BASED ASSESSMENT OF DISEASE SEVERITY IN RIFAMPICIN-RESISTANT TUBERCULOSIS WITH DIABETES ANDCHRONIC KIDNEY DISEASE (CKD)”, Cog. Jou. Res, vol. 1, no. 1, pp. 13–19, Jun. 2026.